 Serotonin Receptor Agonists
"Serotonin Receptor Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS.
| Descriptor ID |
D017366
|
| MeSH Number(s) |
D27.505.519.625.850.800 D27.505.696.577.850.800
|
| Concept/Terms |
Serotonin Receptor Agonists- Serotonin Receptor Agonists
- Agonists, Serotonin Receptor
- 5-HT Agonists
- 5 HT Agonists
- Agonists, 5-HT
- 5-Hydroxytryptamine Agonists
- 5 Hydroxytryptamine Agonists
- Agonists, 5-Hydroxytryptamine
- 5-Hydroxytrytamine Agonist
- 5 Hydroxytrytamine Agonist
- Agonist, 5-Hydroxytrytamine
- Receptor Agonists, Serotonin
- Serotonergic Agonists
- Agonists, Serotonergic
- Serotonin Agonist
- Agonist, Serotonin
- Serotonin Agonists
- Agonists, Serotonin
- Serotonin Receptor Agonist
- Agonist, Serotonin Receptor
- Receptor Agonist, Serotonin
- 5-HT Agonist
- 5 HT Agonist
- Agonist, 5-HT
- Serotonergic Agonist
- Agonist, Serotonergic
|
Below are MeSH descriptors whose meaning is more general than "Serotonin Receptor Agonists".
Below are MeSH descriptors whose meaning is more specific than "Serotonin Receptor Agonists".
This graph shows the total number of publications written about "Serotonin Receptor Agonists" by people in this website by year, and whether "Serotonin Receptor Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Serotonin Receptor Agonists" by people in Profiles.
-
Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol. 2014 Nov; 28(11):983-92.
-
Dickenson JM, Hill SJ. Human 5-HT1B receptor stimulated inositol phospholipid hydrolysis in CHO cells: synergy with Gq-coupled receptors. Eur J Pharmacol. 1998 May 08; 348(2-3):279-85.
-
Salgado-Commissariat D, Alkadhi KA. Serotonin inhibits epileptiform discharge by activation of 5-HT1A receptors in CA1 pyramidal neurons. Neuropharmacology. 1997 Nov-Dec; 36(11-12):1705-12.
-
Salgado-Commissariat D, Alkadhi KA. Effects of serotonin on induced epileptiform activity in CA1 pyramidal neurons of genetically epilepsy prone rats. Brain Res. 1996 Dec 16; 743(1-2):212-6.
-
Alkadhi KA, Salgado-Commissariat D, Hogan YH, Akpaudo SB. Induction and maintenance of ganglionic long-term potentiation require activation of 5-hydroxytryptamine (5-HT3) receptors. J Physiol. 1996 Oct 15; 496 ( Pt 2):479-89.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|